Development of a Multidisciplinary Clinic for Patients After Allogeneic Blood and Marrow Transplantation

2.50
Hdl Handle:
http://hdl.handle.net/10755/165577
Category:
Abstract
Type:
Presentation
Title:
Development of a Multidisciplinary Clinic for Patients After Allogeneic Blood and Marrow Transplantation
Author(s):
Neumann, Joyce
Author Details:
Joyce Neumann, University of Texas, M.D. Anderson Cancer Center, Houston, Texas, USA
Abstract:
The incidence of graft versus host disease (GVHD) in the post allogeneic (allo) blood and marrow transplantation (BMT) patients can approach 70% depending on the degree of disparity. While the incidence of chronic GVHD is less when compared to acute GVHD, the complications can be equally as serious and potentially life threatening. Patient quality of life is often profoundly impaired and there may be a wide variation in management practices. At our comprehensive cancer center over 600 transplantations were performed last year and approximately 60% were allo or matched unrelated donor for patients with a variety of malignancies. We have approximately 13 BMT physicians and 20 midlevel providers (APNs, PA, and PharmDs). The patient care in the pre-BMT and post-BMT first 100 days has been standardized. After the first three months, follow-up varies and data collection and patient outcomes were not consistently analyzed. In trying to explore new treatment options for GVHD patients were frequently missed or not included in potentially beneficial studies. After identification of interested healthcare practitioners from other disciplines, the group met and developed guidelines for the clinic. Representation was obtained from medicine, nursing, pharmacy, physical therapy, social work, and psychiatry. By having a designated contact person in other departments, referrals were made in a much more timely manner. The clinic initially received referral from the BMT physician group, but soon obtained them from research nurses, APNs, and even other patients. An extensive GVHD assessment was developed and performed that included a quality-of-life assessment using the FACT-BMT and the MDASI (M.D. Anderson Assessment of Symptom Inventory). This poster will include data concerning incidence, severity and type of GVHD (limited or extensive), symptom management, and quality-of-life information. A pathway for the treatment of chronic GVHD has been developed as a tool to decrease variation in practice at the cancer center and to educate the community healthcare practitioner concerning the care requirements for these frequently complex patients.
Repository Posting Date:
27-Oct-2011
Date of Publication:
27-Oct-2011
Conference Date:
2002
Conference Name:
27th Annual Oncology Nursing Society Congress
Conference Host:
Oncology Nursing Society
Conference Location:
Washington, D.C., USA
Note:
This is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.

Full metadata record

DC FieldValue Language
dc.type.categoryAbstracten_US
dc.typePresentationen_GB
dc.titleDevelopment of a Multidisciplinary Clinic for Patients After Allogeneic Blood and Marrow Transplantationen_GB
dc.contributor.authorNeumann, Joyceen_US
dc.author.detailsJoyce Neumann, University of Texas, M.D. Anderson Cancer Center, Houston, Texas, USAen_US
dc.identifier.urihttp://hdl.handle.net/10755/165577-
dc.description.abstractThe incidence of graft versus host disease (GVHD) in the post allogeneic (allo) blood and marrow transplantation (BMT) patients can approach 70% depending on the degree of disparity. While the incidence of chronic GVHD is less when compared to acute GVHD, the complications can be equally as serious and potentially life threatening. Patient quality of life is often profoundly impaired and there may be a wide variation in management practices. At our comprehensive cancer center over 600 transplantations were performed last year and approximately 60% were allo or matched unrelated donor for patients with a variety of malignancies. We have approximately 13 BMT physicians and 20 midlevel providers (APNs, PA, and PharmDs). The patient care in the pre-BMT and post-BMT first 100 days has been standardized. After the first three months, follow-up varies and data collection and patient outcomes were not consistently analyzed. In trying to explore new treatment options for GVHD patients were frequently missed or not included in potentially beneficial studies. After identification of interested healthcare practitioners from other disciplines, the group met and developed guidelines for the clinic. Representation was obtained from medicine, nursing, pharmacy, physical therapy, social work, and psychiatry. By having a designated contact person in other departments, referrals were made in a much more timely manner. The clinic initially received referral from the BMT physician group, but soon obtained them from research nurses, APNs, and even other patients. An extensive GVHD assessment was developed and performed that included a quality-of-life assessment using the FACT-BMT and the MDASI (M.D. Anderson Assessment of Symptom Inventory). This poster will include data concerning incidence, severity and type of GVHD (limited or extensive), symptom management, and quality-of-life information. A pathway for the treatment of chronic GVHD has been developed as a tool to decrease variation in practice at the cancer center and to educate the community healthcare practitioner concerning the care requirements for these frequently complex patients.en_GB
dc.date.available2011-10-27T12:21:11Z-
dc.date.issued2011-10-27en_GB
dc.date.accessioned2011-10-27T12:21:11Z-
dc.conference.date2002en_US
dc.conference.name27th Annual Oncology Nursing Society Congressen_US
dc.conference.hostOncology Nursing Societyen_US
dc.conference.locationWashington, D.C., USAen_US
dc.description.noteThis is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.-
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.